Kukje Pharma Co Ltd
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other a… Read more
Kukje Pharma Co Ltd (002720) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.052x
Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has a cash flow conversion efficiency ratio of 0.052x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.99 Billion) by net assets (₩95.32 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kukje Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Kukje Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kukje Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kukje Pharma Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Panama Petrochem Limited
NSE:PANAMAPET
|
0.044x |
|
Alicanto Minerals Ltd
AU:AQI
|
-0.284x |
|
NN Inc
NASDAQ:NNBR
|
0.071x |
|
COGNOR HOLDING ZY 15
F:WO9
|
N/A |
|
Signature Alliance Group Berhad
KLSE:0360
|
0.016x |
|
First Bankers Trustshares Inc
OTCQB:FBTT
|
N/A |
|
FIRST TIN PLC LS-001
F:1SN
|
N/A |
|
SomnoMed Limited
PINK:SOMNF
|
0.080x |
Annual Cash Flow Conversion Efficiency for Kukje Pharma Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Kukje Pharma Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩89.55 Billion | ₩3.94 Billion | 0.044x | +4.54% |
| 2023-12-31 | ₩84.95 Billion | ₩3.58 Billion | 0.042x | -52.06% |
| 2022-12-31 | ₩74.08 Billion | ₩6.50 Billion | 0.088x | -37.26% |
| 2021-12-31 | ₩68.59 Billion | ₩9.60 Billion | 0.140x | +93.42% |
| 2020-12-31 | ₩70.50 Billion | ₩5.10 Billion | 0.072x | +22.36% |
| 2019-12-31 | ₩60.95 Billion | ₩3.60 Billion | 0.059x | -69.34% |
| 2018-12-31 | ₩68.70 Billion | ₩13.25 Billion | 0.193x | +1562.80% |
| 2017-12-31 | ₩67.78 Billion | ₩786.10 Million | 0.012x | -95.14% |
| 2016-12-31 | ₩67.52 Billion | ₩16.10 Billion | 0.238x | +421.30% |
| 2015-12-31 | ₩68.46 Billion | ₩-5.08 Billion | -0.074x | -6075.28% |
| 2014-12-31 | ₩50.85 Billion | ₩-61.11 Million | -0.001x | +98.47% |
| 2013-12-31 | ₩58.33 Billion | ₩-4.60 Billion | -0.079x | -376.04% |
| 2012-12-31 | ₩55.35 Billion | ₩1.58 Billion | 0.029x | -87.72% |
| 2011-12-31 | ₩74.79 Billion | ₩17.39 Billion | 0.232x | -- |